These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9366125

  • 1. Use of sulfasalazine in rheumatic diseases.
    Fuchs HA.
    Bull Rheum Dis; 1997 Nov; 46(7):3-4. PubMed ID: 9366125
    [No Abstract] [Full Text] [Related]

  • 2. Is the cure worse than the disease?
    Sacks R.
    Aust Fam Physician; 2001 Jul; 30(7):679-80. PubMed ID: 11558203
    [No Abstract] [Full Text] [Related]

  • 3. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Borg AA.
    Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
    [No Abstract] [Full Text] [Related]

  • 4. Two is better than one? Combination therapy in rheumatoid arthritis.
    Choy EH.
    Rheumatology (Oxford); 2004 Oct; 43(10):1205-7. PubMed ID: 15226519
    [No Abstract] [Full Text] [Related]

  • 5. Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
    Goodemote P, Jamieson B, Hoffman R.
    J Fam Pract; 2007 Nov; 56(11):933-4, 937. PubMed ID: 17976342
    [No Abstract] [Full Text] [Related]

  • 6. Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Khattak FH, Morris IM, Mattingly PC.
    Br J Rheumatol; 1996 Jan; 35(1):104. PubMed ID: 8624617
    [No Abstract] [Full Text] [Related]

  • 7. [Thrombocytopenia in a patient with rheumatoid arthritis during sulphasalazine therapy].
    Keso L, Kaarela K, Oksanen K, Ahonen M.
    Duodecim; 1998 Jan; 114(17):1731-3. PubMed ID: 11717780
    [No Abstract] [Full Text] [Related]

  • 8. [A chronic gingival hypertrophy].
    Mrabet D, Alaya Z, Bahri SK, Mizouni H, Chelly I, Sahli H, Cheour E, Elleuch M, Haouet S, Jemmali B, Meddeb N, Sellami S.
    Therapie; 2010 Jan; 65(6):585-6. PubMed ID: 21176767
    [No Abstract] [Full Text] [Related]

  • 9. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis.
    Nurmohamed MT, Soesan M, van Oers MH, Dijkmans BA, van Soesbergen RM.
    Rheumatology (Oxford); 2000 Dec; 39(12):1431-3. PubMed ID: 11136894
    [No Abstract] [Full Text] [Related]

  • 10. Sulfasalazine for the management of juvenile rheumatoid arthritis.
    Brooks CD.
    J Rheumatol; 2001 Apr; 28(4):845-53. PubMed ID: 11327261
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Medical management of rheumatoid arthritis].
    Möttönen T.
    Duodecim; 1993 Apr; 109(7):619-24. PubMed ID: 7914869
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Disease-modifying antirheumatic drugs.
    Brasington R.
    J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2000 Jul 10; 42(1082):57-64. PubMed ID: 10887424
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 2. Salazosulfapyridine].
    Kawai S.
    Nihon Naika Gakkai Zasshi; 2011 Oct 10; 100(10):2910-7. PubMed ID: 22175130
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.